TipRanks
Go Ultimate55% OFF

Zain Ebrahim Profile - J.P. Morgan Analyst

4 Followers

Zain Ebrahim's Stock Coverage

GSK
GlaxoSmithKline
Oct 26, 2026SELLReiterated1,700.00 p32Ratings43%-2.66%
BANB
Bachem Holding AG
Sep 10, 2026BUYReiteratedCHF90.004Ratings75%-3.82%
EAPI
Euroapi SA
May 13, 2026HOLDReiterated€1.701Ratings――
HIK
Hikma Pharmaceuticals
Mar 03, 2026BUYReiterated2,000.00 p2Ratings100%+27.90%
OXB
Oxford BioMedica
Dec 08, 2025HOLDReiterated550.00 p1Ratings――
LONN
Lonza Group Ltd
Jul 28, 2025BUYReiteratedCHF675.001Ratings100%+0.10%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Zain Ebrahim activity FAQ

What is the performance of Zain Ebrahim's recommendations?
The percentage of profitable recommendations made by Zain Ebrahim is 57.14%, and the average return per transaction is 0.10%.
What stocks does Zain Ebrahim cover?
Zain Ebrahim mostly covers GlaxoSmithKline, Bachem Holding AG, Euroapi SA stocks.
What was Zain Ebrahim's most profitable rating?
Zain Ebrahim’s most profitable rating was a buy on Hikma Pharmaceuticals stock on Mar 03, 2026. The return on the trade was 40.60%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here